Geron (GERN) late Thursday said lenders Hercules Capital (HTGC) and Silicon Valley Bank have agreed to a $50 million increase to the biopharmaceutical...
Geron (GERN) said late Wednesday it named Faye Feller chief medical officer, effective July 9. Feller succeeds Aleksandra Rizo, who will transition to the...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Geron (GERN) late Friday said it has closed a public offering of common shares and warrants. The offering covered 53.3 million shares and pre-funded...
| Address | 919 East Hillsdale Boulevard Foster City, California 94404 |
| Phone | +1.650.473.7700 |
| Number of Employees | 17 |
| Recent SEC Filing | 06/30/2022 8-K |
| Chairman, President & Chief Executive Officer | John A. Scarlett |
| Chief Operating Officer & Executive Vice President | Andrew J. Grethlein |
| Chief Financial Officer, Treasurer & Executive VP | Olivia K. Bloom |
| Vice President-Clinical Development | Faye Feller |
| Price Open | $1.48 |
| Previous Close | $1.52 |
| 52 Week Range | $0.99 - 1.74 |
| Market Capitalization | $585.0 M |
| Shares Outstanding | 377.4 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 08/15/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$0.36 |
| Beta vs. S&P 500 | N/A |
| Revenue | $1.1 M |
| Net Profit Margin | -8,584.92% |
| Return on Equity | -85.84% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
